Stay updated on GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.

Latest updates to the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page
- Check2 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', signaling that enrollment for this study has closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was adjusted along with a release note for Revision: v3.6.0.SummaryDifference0.5%

- Check9 days agoChange DetectedThe page revision changed from v3.5.4 to v3.5.5, representing a minor update to the ClinicalTrials.gov page rather than a modification of the study data.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe site revision was updated from v3.5.3 to v3.5.4, indicating a new release of the platform. This update reflects backend or UI changes rather than modifications to the study details on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s displayed release/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a minor site maintenance update rather than a change to the trial information.SummaryDifference0.1%

- Check59 days agoChange Detected- Site software revision updated to version v3.5.2.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.